Medicaid患者中疼痛管理治疗与阿片类药物使用障碍风险的关联
Associations between pain-management treatments and opioid use disorder risk among Medicaid patients
AI总结:
本研究针对Medicaid慢性疼痛患者,分析9种疼痛管理治疗与新发OUD的关联,发现阿片类与加巴喷丁或苯二氮䓬类联用、阿片类剂量及时长均升高OUD风险,物理治疗可降低无残疾患者的OUD风险。
摘要:
引言:慢性疼痛患者的阿片类药物滥用风险更高。由于各类疼痛管理治疗通常联合实施,其独立效应存在混杂,目前人们对每种治疗带来的独特风险了解较少。我们在控制基线人口统计学和临床混杂变量、并将其他疼痛管理治疗维持在观测水平的前提下,评估了慢性疼痛患者的疼痛管理策略与新发阿片类药物使用障碍(OUD)风险的关联程度。\n方法:我们使用了2016-2019年来自25个州、年龄在35-64岁的非妊娠Medicaid患者队列中的两个慢性疼痛亚组数据:1)伴有身体残疾共病的慢性疼痛患者(N=6133),2)无残疾的慢性疼痛患者(N=67438)。我们纳入了9种疼痛管理治疗:处方阿片类药物的i)剂量和ii)持续时间;iii)阿片类药物处方医生数量;阿片类药物与iv)苯二氮䓬类、v)肌肉松弛剂、vi)加巴喷丁类药物的联合处方;vii)非阿片类疼痛处方药、viii)物理治疗、ix)其他疼痛治疗方式。研究结局为新发OUD。\n结果:阿片类药物与加巴喷丁联合处方,或阿片类药物与苯二氮䓬类联合处方,与OUD风险升高16%-46%具有统计学显著关联。阿片类药物的剂量和持续时间也与OUD风险升高显著相关。在无残疾的慢性疼痛亚组中,物理治疗与OUD风险降低11%显著相关。\n结论:阿片类药物与加巴喷丁或苯二氮䓬类的联合处方可能会大幅增加OUD风险。更积极的是,物理治疗可能是一种相对易得且安全的疼痛管理策略。
英文摘要:
Introduction: Chronic pain patients are at increased risk of opioid-misuse. Less is known about the unique risk conferred by each pain-management treatment, as treatments are typically implemented together, confounding their independent effects. We estimated the extent to which pain-management strategies were associated with risk of incident opioid use disorder (OUD) for those with chronic pain, controlling for baseline demographic and clinical confounding variables and holding other pain-management treatments at their observed levels. Methods: We used data from two chronic pain subgroups within a cohort of non-pregnant Medicaid patients aged 35-64 years, 2016-2019, from 25 states: 1) those with a chronic pain condition co-morbid with physical disability (N=6,133) or 2) those with chronic pain without disability (N=67,438). We considered 9 pain-management treatments: prescription opioid i) dose and ii) duration; iii) number of opioid prescribers; opioid co-prescription with iv) benzodiazepines, v) muscle relaxants, and vi) gabapentinoids; vii) non-opioid pain prescription, viii) physical therapy, and ix) other pain treatment modality. Our outcome was incident OUD. Results: Having an opioid and gabapentin co-prescription or an opioid and benzodiazepine co-prescription was statistically significantly associated with a 16-46% increased risk of OUD. Opioid dose and duration also were significantly associated with increased risk of OUD. Physical therapy was significantly associated with an 11% decreased risk of OUD in the subgroup with chronic pain but no disability. Conclusions: Co-prescription of opioids with either gabapentin or benzodiazepines may substantially increase risk of OUD. More positively, physical therapy may be a relatively accessible and safe pain-management strategy.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。